Investor Relations

Subscribe to our mailing list!


Adherium is a provider of digital health solutions that address sub-optimal medication use and improve health outcomes in chronic disease. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of device sensors for respiratory medications. The first Smartinhaler™ device was developed for use in clinical trials in 2003, and since then the Company has expanded its technology platform and Smartinhaler™ product range. Adherium operates globally from bases in the USA, Europe and Australasia.

Latest Announcements